Tkt Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
TKT (Transketolase) encodes a crucial enzyme in the non-oxidative branch of the pentose phosphate pathway (PPP). Transketolase plays a vital role in cellular redox homeostasis through NADPH production and provides ribose-5-phosphate for nucleotide biosynthesis. TKT has been extensively studied in neurodegeneration due to its sensitivity to thiamine (vitamin B1) deficiency and its role in oxidative stress response. Dysregulated TKT function has been implicated in Alzheimer's Disease (AD), Wernicke-Korsakoff Syndrome, Parkinson's Disease (PD), and diabetic neuropathy. The gene is located on chromosome 3p21.1 and encodes a 623-amino acid protein.
| Attribute |
Value |
| Symbol |
TKT |
| Full Name |
Transketolase |
| Chromosomal Location |
3p21.1 |
| NCBI Gene ID |
7086 |
| OMIM |
177027 |
| Ensembl ID |
ENSG00000163798 |
| UniProt ID |
P29597 |
| Protein Length |
623 amino acids |
| Molecular Weight |
67.8 kDa |
Transketolase is a homodimeric enzyme with distinct functional domains:
- N-terminal domain (residues 1-320): Contains the binding site for donor substrate (sedoheptulose-7-P or xylulose-5-P)
- C-terminal domain (residues 321-623): Contains the binding site for acceptor substrate (ribose-5-P or glyceraldehyde-3-P)
- Thiamine pyrophosphate (TPP) binding pocket: Central catalytic site requiring TPP as cofactor
- Dimer interface: Required for enzyme stability and activity
The enzyme requires TPP and Mg²⁺/Ca²⁺ as essential cofactors.
Transketolase catalyzes transfers of two-carbon units in the non-oxidative PPP:
- Sedoheptulose-7-P + glyceraldehyde-3-P → ribose-5-P + fructose-6-P
- Xylulose-5-P + glyceraldehyde-3-P → fructose-6-P + erythrose-4-P
- Connects glycolysis to PPP: Enables interconversion of glycolytic and PPP intermediates
- Ribose-5-P production: Essential for nucleotide and nucleic acid synthesis
- NADPH precursor: Supports reductive biosynthesis and antioxidant defense
- Erythrose-4-P production: Precursor for aromatic amino acid synthesis
- High expression in neurons and astrocytes
- Critical for maintaining NADPH pools in brain tissue
- Supports antioxidant defense via glutathione regeneration
TKT dysfunction in AD is well-characterized:
- Reduced TKT activity in AD brains (40-60% of normal) (PMID: 7535719)
- Thiamine deficiency is common in AD and contributes to cognitive decline
- Impaired PPP function leads to reduced NADPH and increased oxidative stress
- TPP cofactor levels are reduced in AD brain tissue
- TKT decline correlates with disease severity
- TKT is highly sensitive to thiamine deficiency
- Thiamine deficiency dramatically reduces TKT activity
- Wernicke's encephalopathy involves PPP dysfunction
- Thiamine supplementation improves TKT function
- PPP dysfunction contributes to oxidative stress in dopaminergic neurons
- Reduced NADPH compromises glutathione antioxidant defense
- TKT activity is impaired in PD substantia nigra
- Thiamine supplementation has been explored in PD models
- TKT activity is reduced in diabetic conditions
- Hyperglycemia impairs PPP function
- Contributes to diabetic neuropathy pathogenesis
¶ Thiamine and TPP Supplementation
- Thiamine (vitamin B1): Oral supplementation may improve TKT function
- Thiamine pyrophosphate (TPP): Direct cofactor supplementation
- Benfotiamine: Lipid-soluble thiamine derivative with better brain penetration
- Clinical trials have shown modest benefits in AD and diabetic neuropathy
- Compounds that stimulate PPP flux
- NADPH-boosting strategies
- Antioxidant approaches targeting PPP dysfunction
TKT interacts with:
- TKT11/TKT2: Alternative splicing isoforms
- G6PD: First enzyme of oxidative PPP branch
- 6PGL: 6-phosphogluconolactonase
- PGD: 6-phosphogluconate dehydrogenase
- RPE: Ribulose-5-phosphate 3-epimerase
- PRPS: Phosphoribosyl pyrophosphate synthetase
- GSTA1-4: Glutathione S-transferases (NADPH-dependent)
- TXN: Thioredoxin system
Tkt Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Tkt Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Gibson GE, et al. (1988). Transketolase activity in Alzheimer's disease. Journal of Neurochemistry. PMID:7535719
- Calingasan NY, et al. (1995). Thiamine-dependent enzyme changes in Alzheimer's disease. Brain Research. PMID:7789261
- Mastrogiacoma F, et al. (1996). Transketolase and tau protein in Alzheimer's disease. Annals of Neurology. PMID:8774917
- Heroux M, et al. (1999). Thiamine pyrophosphate and thiamine phosphate in brain. Journal of Neurochemistry. PMID:10386971
- Park LC, et al. (1999). Metabolic dysfunction in Alzheimer's disease: from the mitochondrial perspective. Journal of Bioenergetics and Biomembranes. PMID:10458917
- Zhou J, et al. (2011). Benfotiamine improves functional recovery in diabetic neuropathy. Diabetologia. PMID:21573954